#1 Clinical Trials Search in Europe

Propafenone Hydrochloride

Propafenone hydrochloride is an antiarrhythmic medication used to treat various heart rhythm disorders, particularly atrial fibrillation. Recent clinical trials have been exploring new formulations, applications, and comparisons of propafenone to better understand its efficacy and safety profile. These studies aim to improve treatment options for patients with cardiac arrhythmias and provide valuable insights into the drug’s pharmacokinetics and pharmacodynamics.

Table of Contents

What is Propafenone Hydrochloride?

Propafenone Hydrochloride is a medication used to treat certain types of irregular heartbeats. It belongs to a class of drugs called antiarrhythmics, which help control heart rhythm problems. Propafenone is also known by brand names such as Rythmol SR®, Rhynorm, and Rytmonorm[1][3].

Medical Uses

Propafenone Hydrochloride is primarily used to treat the following conditions:

  • Atrial Fibrillation (AF): This is a common heart rhythm disorder where the upper chambers of the heart (atria) beat irregularly and often too fast. Propafenone helps to restore and maintain a normal heart rhythm in patients with AF[2][4].
  • Atrial Flutter: Another type of irregular heart rhythm that propafenone can help manage[2].
  • Ventricular Arrhythmias: These are irregular heartbeats originating from the lower chambers of the heart (ventricles). Propafenone can be used to treat certain types of ventricular arrhythmias[5].
  • Premature Ventricular Complexes (PVCs): These are extra, abnormal heartbeats that start in the ventricles. Propafenone has been studied for its effectiveness in reducing PVCs[5].

How Propafenone Works

Propafenone works by slowing the flow of electrical signals in the heart. This helps to stabilize the heart rhythm and prevent irregular heartbeats. It does this by blocking certain channels in heart cells that are responsible for the movement of ions like sodium and potassium. By altering these electrical signals, propafenone can help restore a normal heart rhythm[2].

Different Formulations

Propafenone Hydrochloride comes in different formulations:

  • Tablets: Regular tablets that are typically taken multiple times a day[3].
  • Extended-release capsules: These are designed to release the medication slowly over time, allowing for less frequent dosing[1].
  • Intravenous (IV) form: Used in hospital settings for rapid treatment of certain arrhythmias[7].

How It’s Administered

The way propafenone is given depends on the formulation and the patient’s specific condition:

  • Oral tablets: These are typically taken 2-3 times per day with or without food[3].
  • Extended-release capsules: Usually taken once or twice daily[1].
  • Intravenous administration: In hospital settings, propafenone may be given as an IV infusion over a period of time[7].

The dosage is determined by your doctor based on your specific condition, response to treatment, and other factors. It’s important to take this medication exactly as prescribed and not to stop taking it without consulting your doctor.

Effectiveness

Research has shown that propafenone can be effective in treating various heart rhythm disorders:

  • In patients with atrial fibrillation, propafenone has been shown to be effective in converting the heart back to normal rhythm and preventing recurrence of AF[4].
  • Studies have compared propafenone to other antiarrhythmic drugs. For example, one study compared propafenone to dronedarone for maintaining normal heart rhythm after cardioversion (a procedure to restore normal heart rhythm) in patients with atrial fibrillation[8].
  • Propafenone has also shown effectiveness in reducing premature ventricular complexes (PVCs)[5].

Potential Side Effects

Like all medications, propafenone can cause side effects. Common side effects may include:

  • Dizziness
  • Nausea
  • Unusual taste in the mouth
  • Constipation
  • Headache

More serious side effects can occur, although they are less common. These may include worsening of existing arrhythmias or development of new arrhythmias. It’s important to report any unusual symptoms to your healthcare provider[1][3].

Ongoing Research

Research on propafenone is ongoing to better understand its effects and potential uses:

  • A study is investigating the pharmacokinetics (how the body processes the drug) of propafenone in children, as its use in pediatric patients is currently based mostly on clinical experience[6].
  • Another study is comparing the effectiveness of propafenone to amiodarone (another antiarrhythmic drug) in patients with septic shock who develop supraventricular arrhythmias[7].
  • Researchers are also studying different formulations of propafenone. One study is looking at the bioequivalence (how similar the effects are) of propafenone tablets manufactured at different sites[1].

These ongoing studies aim to improve our understanding of propafenone and optimize its use in different patient populations.

Aspect Details
Study Types Bioequivalence studies, comparative efficacy trials, pharmacokinetic studies
Formulations Oral tablets, intravenous infusions, (R)-propafenone, (S)-propafenone
Patient Populations Adults with atrial fibrillation, children with arrhythmias, patients with septic shock
Comparators Amiodarone, beta-blockers (e.g., propranolol), placebo
Primary Outcomes Arrhythmia reduction, pharmacokinetic parameters (Cmax, AUC), cardioversion rates
Safety Assessments Adverse events, vital signs, ECG changes, laboratory tests
Novel Applications Treatment of arrhythmias in septic shock, pediatric use

FAQ

  • What is propafenone hydrochloride used for? Propafenone hydrochloride is primarily used to treat atrial fibrillation and other cardiac arrhythmias. It works by helping to restore and maintain a normal heart rhythm.
  • Are there different formulations of propafenone being studied? Yes, clinical trials are investigating various formulations of propafenone, including different manufacturing sites for the same drug, as well as comparing the efficacy of (R)-propafenone and (S)-propafenone separately.
  • How is propafenone being compared to other medications? Some studies are comparing propafenone to other antiarrhythmic drugs like amiodarone, as well as to beta-blockers like propranolol, to determine their relative efficacy in treating arrhythmias.
  • What are the main outcomes being measured in propafenone clinical trials? The main outcomes include the drug's ability to reduce or prevent atrial fibrillation episodes, its pharmacokinetic properties (like maximum concentration and area under the curve), and its safety profile, including any adverse events.
  • Are there any studies looking at propafenone use in specific patient groups? Yes, some trials are focusing on propafenone use in children, while others are investigating its efficacy in patients with septic shock who develop supraventricular arrhythmias.

Ongoing Clinical Trials on Propafenone Hydrochloride

  • Study of drug combination therapy for prevention of recurrent stroke in patients with acute ischemic stroke and atrial fibrillation

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany The Netherlands Spain

  • Study of drug combination therapy in asymptomatic patients with frequent premature ventricular contractions and normal heart function to prevent left ventricular dysfunction

    Recruiting

    3 1 1 1
    Investigated drugs:
    France

  • Comparison of Etacizine and Propafenone for maintaining normal heart rhythm in patients with atrial fibrillation

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Latvia

Glossary

  • Atrial Fibrillation: A common heart rhythm disorder characterized by irregular and often rapid heartbeat, which can increase the risk of stroke and other complications.
  • Bioequivalence: The property of two drug products having the same biological effect in the body, typically measured by comparing their absorption and concentration in the bloodstream.
  • Pharmacokinetics: The study of how a drug moves through the body, including its absorption, distribution, metabolism, and excretion.
  • Cmax: The maximum concentration of a drug observed in the blood after administration.
  • AUC: Area Under the Curve, a measure of the total exposure to a drug over time.
  • Premature Ventricular Complex: Extra heartbeats that originate in the ventricles (lower chambers of the heart) and disrupt the normal heart rhythm.
  • Supraventricular Arrhythmia: Abnormal heart rhythms that start in the upper chambers of the heart (atria) or the area above the ventricles.
  • Septic Shock: A life-threatening condition caused by a severe infection that leads to dangerously low blood pressure and organ failure.
  • Antiarrhythmic: A type of medication used to treat and prevent abnormal heart rhythms.
  • Beta-blocker: A class of medications that block the effects of adrenaline on the heart, often used to treat high blood pressure and certain arrhythmias.

References

  1. https://clinicaltrials.gov/study/NCT01956487
  2. https://clinicaltrials.gov/study/NCT02710669
  3. https://clinicaltrials.gov/study/NCT03915340
  4. https://clinicaltrials.gov/study/NCT03674658
  5. https://clinicaltrials.gov/study/NCT03561935
  6. https://clinicaltrials.gov/study/NCT05463614
  7. https://clinicaltrials.gov/study/NCT03029169
  8. https://clinicaltrials.gov/study/NCT01991119